Venus Concept Inc. (NASDAQ:VERO - Get Free Report) Director Anthony Natale sold 42,768 shares of the business's stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $0.31, for a total transaction of $13,258.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Venus Concept Price Performance
Shares of VERO opened at $0.32 on Thursday. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. Venus Concept Inc. has a 1 year low of $0.28 and a 1 year high of $2.22. The company's fifty day moving average is $0.42 and its two-hundred day moving average is $0.57.
Hedge Funds Weigh In On Venus Concept
A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC lifted its stake in shares of Venus Concept Inc. (NASDAQ:VERO - Free Report) by 100.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 666,702 shares of the company's stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent quarter. 87.41% of the stock is currently owned by institutional investors.
About Venus Concept
(
Get Free Report)
AI Crypto Tool Could Send One Coin SOARING…
From Crypto 101 Media | Ad
The #1 AI Coin to Buy
Rapid growth predicted for little-known AI crypto project
Discover our #1 crypto pick before it's too late.
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
